Tumor molecular typing and drug sensitivity prediction model based on artificial intelligence
Project background:
Tumor is a kind of disease caused by gene mutation, cell proliferation is out of control, which poses a great threat to human health. At present, the treatment of tumors mainly relies on traditional methods such as surgery, radiation and chemotherapy, but these methods are often accompanied by high toxic side effects and low cure rates. With the development of molecular biology and genomics, tumor molecular typing and targeted drug therapy have become an important part of tumor precision medicine, aiming to select the most appropriate drugs according to the specific molecular markers of tumor cells, improve the therapeutic effect and reduce adverse reactions. However, at present, there are still some challenges in tumor molecular typing and drug sensitivity prediction, such as tumor heterogeneity, drug resistance, biomarker selection, drug screening, etc., which need to be solved with the help of more advanced technologies and methods.
Project information: This project aims to use artificial intelligence technology to establish tumor molecular typing and drug sensitivity prediction models based on multi-omics data (such as genome, transcriptome, proteome, etc.), so as to provide personalized treatment for tumor patients. This project will use machine learning and deep learning methods to extract effective features and patterns from large-scale tumor cell lines and clinical samples, build and optimize predictive models, and perform validation and evaluation. This topic will cover the following aspects:
Project content:
Data acquisition and preprocessing: Obtain multiple omics data from a public database or partner institution, and perform quality control, normalization, dimensionality reduction and other preprocessing steps to facilitate subsequent analysis.
Feature selection and extraction: Statistical learning or deep learning methods are used to screen out features related to tumor molecular typing and drug sensitivity from multi-omics data, and carry out feature extraction and fusion to form a high-dimensional feature space.
Model construction and optimization: Using methods such as machine learning or deep learning, based on feature space and drug response data, establish regression or classification types of predictive models, and use cross-validation, grid search and other methods for model optimization and parameter adjustment.
Model validation and evaluation: Validation of predictive models using independent test sets or external data sets, and evaluation of models using metrics such as correlation coefficients, mean square error, accuracy, recall rates, and comparison with existing methods.
Model application and generalization: Apply predictive models to actual tumor patient samples, provide personalized treatment recommendations based on the model output, and explore the applicability and universality of the model in different types, different stages, and different sources of tumors.
Topic innovation:
This project will use artificial intelligence technology combined with multi-omics data to establish a comprehensive and accurate tumor molecular typing and drug sensitivity prediction model, providing new ideas and methods for tumor precision medicine.
This project will use advanced algorithms such as machine learning and deep learning to learn effective features and patterns from large-scale tumor cell lines and clinical samples to improve the performance and accuracy of predictive models.
This project will systematically validate and evaluate the predictive model, compare it with existing methods, demonstrate the advantages and limitations of the model, and explore the application and promotion potential of the model in different tumor scenarios.
Tumor is a kind of disease caused by gene mutation, cell proliferation is out of control, which poses a great threat to human health. At present, the treatment of tumors mainly relies on traditional methods such as surgery, radiation and chemotherapy, but these methods are often accompanied by high toxic side effects and low cure rates. With the development of molecular biology and genomics, tumor molecular typing and targeted drug therapy have become an important part of tumor precision medicine, aiming to select the most appropriate drugs according to the specific molecular markers of tumor cells, improve the therapeutic effect and reduce adverse reactions. However, at present, there are still some challenges in tumor molecular typing and drug sensitivity prediction, such as tumor heterogeneity, drug resistance, biomarker selection, drug screening, etc., which need to be solved with the help of more advanced technologies and methods.
Project information: This project aims to use artificial intelligence technology to establish tumor molecular typing and drug sensitivity prediction models based on multi-omics data (such as genome, transcriptome, proteome, etc.), so as to provide personalized treatment for tumor patients. This project will use machine learning and deep learning methods to extract effective features and patterns from large-scale tumor cell lines and clinical samples, build and optimize predictive models, and perform validation and evaluation. This topic will cover the following aspects:
Project content:
Data acquisition and preprocessing: Obtain multiple omics data from a public database or partner institution, and perform quality control, normalization, dimensionality reduction and other preprocessing steps to facilitate subsequent analysis.
Feature selection and extraction: Statistical learning or deep learning methods are used to screen out features related to tumor molecular typing and drug sensitivity from multi-omics data, and carry out feature extraction and fusion to form a high-dimensional feature space.
Model construction and optimization: Using methods such as machine learning or deep learning, based on feature space and drug response data, establish regression or classification types of predictive models, and use cross-validation, grid search and other methods for model optimization and parameter adjustment.
Model validation and evaluation: Validation of predictive models using independent test sets or external data sets, and evaluation of models using metrics such as correlation coefficients, mean square error, accuracy, recall rates, and comparison with existing methods.
Model application and generalization: Apply predictive models to actual tumor patient samples, provide personalized treatment recommendations based on the model output, and explore the applicability and universality of the model in different types, different stages, and different sources of tumors.
Topic innovation:
This project will use artificial intelligence technology combined with multi-omics data to establish a comprehensive and accurate tumor molecular typing and drug sensitivity prediction model, providing new ideas and methods for tumor precision medicine.
This project will use advanced algorithms such as machine learning and deep learning to learn effective features and patterns from large-scale tumor cell lines and clinical samples to improve the performance and accuracy of predictive models.
This project will systematically validate and evaluate the predictive model, compare it with existing methods, demonstrate the advantages and limitations of the model, and explore the application and promotion potential of the model in different tumor scenarios.
| Kind reminder: Suzhou Beike Nano supply products are only used for scientific research and cannot be used for the human body. The specifications and performance of different batches of products may vary. Some literature case images on the website are sourced from the internet and are for reference only. Please focus on physical objects. If there is any infringement, please contact us to delete them immediately. |
Previous article： Heterogeneity and meta
Next article： Life Sciences - Micro-
